• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

真核多胺脱乙酰酶“人源化”斑马鱼组蛋白脱乙酰酶10(HDAC10)的表达、纯化及结晶

Expression, purification, and crystallization of "humanized" Danio rerio histone deacetylase 10 "HDAC10", the eukaryotic polyamine deacetylase.

作者信息

Goulart Stollmaier Juana, Herbst-Gervasoni Corey J, Christianson David W

机构信息

Roy and Diana Vagelos Laboratories, Department of Chemistry, University of Pennsylvania, Philadelphia, PA, United States.

Roy and Diana Vagelos Laboratories, Department of Chemistry, University of Pennsylvania, Philadelphia, PA, United States.

出版信息

Methods Enzymol. 2025;715:19-40. doi: 10.1016/bs.mie.2025.01.074. Epub 2025 Feb 11.

DOI:10.1016/bs.mie.2025.01.074
PMID:40382137
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12228987/
Abstract

The class IIb histone deacetylase HDAC10 is responsible for the deacetylation of intracellular polyamines, in particular N-acetylspermidine. HDAC10 is emerging as an attractive target for drug design owing to its role as an inducer of autophagy, and high-resolution crystal structures enable structure-based drug design efforts. The only crystal structure available to date is that of HDAC10 from Danio rerio (zebrafish), but a construct containing the A24E and D94A substitutions yields an active site contour that more closely resembles that of human HDAC10. The use of this "humanized" construct has advanced our understanding of HDAC10-inhibitor structure-activity relationships. Here, we outline the preparation, purification, assay, and crystallization of humanized zebrafish HDAC10-inhibitor complexes. The plasmid containing the humanized zebrafish HDAC10 construct for heterologous expression in Escherichia coli is available through Addgene (#225542).

摘要

IIb类组蛋白去乙酰化酶HDAC10负责细胞内多胺的去乙酰化,尤其是N - 乙酰亚精胺。由于其作为自噬诱导剂的作用,HDAC10正成为药物设计的一个有吸引力的靶点,并且高分辨率晶体结构有助于基于结构的药物设计研究。迄今为止唯一可用的晶体结构是来自斑马鱼的HDAC10,但含有A24E和D94A替换的构建体产生的活性位点轮廓与人类HDAC10的活性位点轮廓更相似。这种“人源化”构建体的使用推进了我们对HDAC10 - 抑制剂构效关系的理解。在这里,我们概述了人源化斑马鱼HDAC10 - 抑制剂复合物的制备、纯化、测定和结晶。含有用于在大肠杆菌中异源表达的人源化斑马鱼HDAC10构建体的质粒可通过Addgene(#225542)获得。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18c4/12228987/efe022fd67eb/nihms-2094350-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18c4/12228987/f08ac72054f0/nihms-2094350-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18c4/12228987/d68ebd7d32ce/nihms-2094350-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18c4/12228987/40b16c5becbe/nihms-2094350-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18c4/12228987/6d9e4a6b2ecc/nihms-2094350-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18c4/12228987/b4e381c3a95b/nihms-2094350-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18c4/12228987/4039605c8406/nihms-2094350-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18c4/12228987/efe022fd67eb/nihms-2094350-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18c4/12228987/f08ac72054f0/nihms-2094350-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18c4/12228987/d68ebd7d32ce/nihms-2094350-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18c4/12228987/40b16c5becbe/nihms-2094350-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18c4/12228987/6d9e4a6b2ecc/nihms-2094350-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18c4/12228987/b4e381c3a95b/nihms-2094350-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18c4/12228987/4039605c8406/nihms-2094350-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/18c4/12228987/efe022fd67eb/nihms-2094350-f0007.jpg

相似文献

1
Expression, purification, and crystallization of "humanized" Danio rerio histone deacetylase 10 "HDAC10", the eukaryotic polyamine deacetylase.真核多胺脱乙酰酶“人源化”斑马鱼组蛋白脱乙酰酶10(HDAC10)的表达、纯化及结晶
Methods Enzymol. 2025;715:19-40. doi: 10.1016/bs.mie.2025.01.074. Epub 2025 Feb 11.
2
Structural Basis for the Selective Inhibition of HDAC10, the Cytosolic Polyamine Deacetylase.结构基础上的选择性抑制 hDAC10,细胞质多胺脱乙酰酶。
ACS Chem Biol. 2020 Aug 21;15(8):2154-2163. doi: 10.1021/acschembio.0c00362. Epub 2020 Jul 23.
3
Histone deacetylase 10 structure and molecular function as a polyamine deacetylase.组蛋白去乙酰化酶 10 的结构和分子功能作为一种多胺去乙酰化酶。
Nat Commun. 2017 May 18;8:15368. doi: 10.1038/ncomms15368.
4
Binding of -Acetylspermidine Analogues to Histone Deacetylase 10 Reveals Molecular Strategies for Blocking Polyamine Deacetylation.-乙酰 spermidine 类似物与组蛋白去乙酰化酶 10 的结合揭示了阻止多胺去乙酰化的分子策略。
Biochemistry. 2019 Dec 10;58(49):4957-4969. doi: 10.1021/acs.biochem.9b00906. Epub 2019 Dec 2.
5
Methods for the expression, purification, and crystallization of histone deacetylase 6-inhibitor complexes.组蛋白去乙酰化酶6抑制剂复合物的表达、纯化及结晶方法。
Methods Enzymol. 2019;626:447-474. doi: 10.1016/bs.mie.2019.06.028. Epub 2019 Jul 18.
6
X-ray Crystallographic Snapshots of Substrate Binding in the Active Site of Histone Deacetylase 10.X 射线晶体学快照:组蛋白去乙酰化酶 10 活性位点中的底物结合。
Biochemistry. 2021 Feb 2;60(4):303-313. doi: 10.1021/acs.biochem.0c00936. Epub 2021 Jan 15.
7
The protein deacetylase HDAC10 controls DNA replication in malignant lymphoid cells.蛋白质脱乙酰酶HDAC10控制恶性淋巴细胞中的DNA复制。
Leukemia. 2025 Apr 29. doi: 10.1038/s41375-025-02612-8.
8
Polyamine Deacetylase Structure and Catalysis: Prokaryotic Acetylpolyamine Amidohydrolase and Eukaryotic HDAC10.多胺脱乙酰酶的结构与催化作用:原核生物乙酰多胺酰胺水解酶和真核生物HDAC10
Biochemistry. 2018 Jun 5;57(22):3105-3114. doi: 10.1021/acs.biochem.8b00079. Epub 2018 Mar 21.
9
Cell-based determination of HDAC10-mediated polyamine deacetylase activity.基于细胞的HDAC10介导的多胺脱乙酰酶活性测定。
Methods Enzymol. 2025;715:337-349. doi: 10.1016/bs.mie.2025.01.047. Epub 2025 Feb 22.
10
Histone deacetylase-10 liberates spermidine to support polyamine homeostasis and tumor cell growth.组蛋白去乙酰化酶-10 释放亚精胺以支持多胺稳态和肿瘤细胞生长。
J Biol Chem. 2022 Oct;298(10):102407. doi: 10.1016/j.jbc.2022.102407. Epub 2022 Aug 19.

本文引用的文献

1
Design, Synthesis, and Structural Evaluation of Acetylated Phenylthioketone Inhibitors of HDAC10.组蛋白去乙酰化酶10(HDAC10)的乙酰化苯硫酮抑制剂的设计、合成及结构评估
ACS Med Chem Lett. 2024 Sep 5;15(10):1715-1723. doi: 10.1021/acsmedchemlett.4c00293. eCollection 2024 Oct 10.
2
Recent and anticipated novel drug approvals (Q2 2024 through Q1 2025).近期及预期的新型药物批准情况(2024年第二季度至2025年第一季度)
Am J Health Syst Pharm. 2024 Aug 12;81(16):733-738. doi: 10.1093/ajhp/zxae148.
3
FDA approves an HDAC inhibitor for Duchenne muscular dystrophy.
美国食品药品监督管理局批准一种组蛋白去乙酰化酶抑制剂用于治疗杜氏肌营养不良症。
Nat Rev Drug Discov. 2024 May;23(5):329. doi: 10.1038/d41573-024-00066-8.
4
Chemical Versatility in Catalysis and Inhibition of the Class IIb Histone Deacetylases.催化和抑制 IIb 类组蛋白去乙酰化酶中的化学多功能性。
Acc Chem Res. 2024 Apr 16;57(8):1135-1148. doi: 10.1021/acs.accounts.3c00801. Epub 2024 Mar 26.
5
Safety and efficacy of givinostat in boys with Duchenne muscular dystrophy (EPIDYS): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. givinostat 在患有杜氏肌营养不良症(EPIDYS)男孩中的安全性和有效性:一项多中心、随机、双盲、安慰剂对照、3 期临床试验。
Lancet Neurol. 2024 Apr;23(4):393-403. doi: 10.1016/S1474-4422(24)00036-X.
6
UniProt: the Universal Protein Knowledgebase in 2023.UniProt:2023 年的通用蛋白质知识库。
Nucleic Acids Res. 2023 Jan 6;51(D1):D523-D531. doi: 10.1093/nar/gkac1052.
7
Aza-SAHA Derivatives Are Selective Histone Deacetylase 10 Chemical Probes That Inhibit Polyamine Deacetylation and Phenocopy HDAC10 Knockout.氮杂萨洒衍生物是选择性组蛋白去乙酰化酶 10 化学探针,可抑制多胺去乙酰化并表型模拟 HDAC10 基因敲除。
J Am Chem Soc. 2022 Oct 19;144(41):18861-18875. doi: 10.1021/jacs.2c05030. Epub 2022 Oct 6.
8
Global crotonylome reveals hypoxia-mediated lamin A crotonylation regulated by HDAC6 in liver cancer.全球 crotonylome 揭示了缺氧介导的 lamin A crotonylation 受肝癌中 HDAC6 的调控。
Cell Death Dis. 2022 Aug 17;13(8):717. doi: 10.1038/s41419-022-05165-1.
9
Identification of histone deacetylase 10 (HDAC10) inhibitors that modulate autophagy in transformed cells.鉴定组蛋白去乙酰化酶 10(HDAC10)抑制剂,调节转化细胞中的自噬。
Eur J Med Chem. 2022 Apr 15;234:114272. doi: 10.1016/j.ejmech.2022.114272. Epub 2022 Mar 11.
10
Recent developments of HDAC inhibitors: Emerging indications and novel molecules.新型组蛋白去乙酰化酶抑制剂的研究进展:新的适应证和新的分子。
Br J Clin Pharmacol. 2021 Dec;87(12):4577-4597. doi: 10.1111/bcp.14889. Epub 2021 May 27.